• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Pavmed

Pavmed closes $4m offering

January 24, 2018 By Fink Densford

Pavmed (NSDQ:PAVM) said today it closed a previously announced public offering, raising approximately $3.9 million which it plans to use for working capital and general corporate purposes. Money raised in the round came through the sale of 2.4 million shares of its common stock at a price of $1.80 per share, the New York City-based company […]

Filed Under: Business/Financial News Tagged With: Pavmed

Pavmed prices $4.3m offering

January 19, 2018 By Sarah Faulkner

Pavmed (NSDQ:PAVM) today priced an underwritten public offering of 2,415,278 shares of its common stock at $1.80 per share. The New York City-based company said it would grant the offering’s underwriters a 45-day option to buy up to 362,292 additional shares of common stock to cover over-allotments. Pavmed expects to bring in $3.9 million in net […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Pavmed

Pavmed registers $90m offering

January 18, 2018 By Sarah Faulkner

Pavmed (NSDQ:PAVM) has registered for a nearly $90 million offering, saying it plans to float the rights to buy up to 14.6 million units. The New York City-based company said it would issue a single unit for each share of common stock. Each unit is slated to include one common share and a six-year Series Z warrant worth […]

Filed Under: Business/Financial News, Funding Roundup, Wall Street Beat Tagged With: Pavmed

Pavmed sets terms for warrants offering

January 17, 2018 By Sarah Faulkner

Pavmed (NSDQ:PAVM) said today that it set the terms for a forthcoming rights offering, saying it plans to issue a single unit for each share of common stock. Each unit will include one common share and a six-year Series Z warrant worth $2.25 per share, redeemable at $3 each, the New York City-based company said. Last […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Pavmed

Pavmed cuts warrant price again

January 11, 2018 By Sarah Faulkner

Pavmed (NSDQ:PAVM) said today it would cut the cash exercise price of each of its Series W warrants from $2.50 to $2.00 apiece. This is the second price cut that Pavmed has given for its outstanding warrants. Each of the New York-based company’s outstanding warrants were exercisable at $5.00 apiece for one share of common stock […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Pavmed

Pavmed offers warrants at half-price to raise cash for carpal tunnel syndrome device

December 29, 2017 By Sarah Faulkner

Pavmed (NSDQ:PAVM) said this week that it plans to temporarily cut the exercise price of its outstanding Series W warrants in half. Each of the New York-based company’s outstanding warrants is currently exercisable at $5.00 apiece for one share of common stock. After Pavmed files tender offer materials, each warrant will have an exercise price of […]

Filed Under: Funding Roundup, Pain Management, Wall Street Beat Tagged With: Pavmed

Pavmed files FDA 510(k) for CarpX carpal tunnel device

November 28, 2017 By Fink Densford

Pavmed (NSDQ:PAVM) said today it filed a 510(k) application with the FDA for its CarpX minimally invasive device designed to treat carpal tunnel syndrome. The CarpX is a percutaneous device designed to allow the operating physician to relieve compression of the median nerve without a surgical incision. The system combines a balloon catheter with bipolar radio-frequency […]

Filed Under: 510(k), Food & Drug Administration (FDA), Pain Management, Regulatory/Compliance Tagged With: Pavmed

Pavmed shares climb after Q3 EPS beat

November 15, 2017 By Sarah Faulkner

Shares in Pavmed Inc. (NSDQ:PAVM) rose today after the medical device maker beat expectations on Wall Street with its third quarter results. The N.Y.-based company posted a net loss of -$5.37 million, or -40¢ per share, for the 3 months ended Sept. 30, for bottom-line loss of -178.5% compared with the same period last year. Get the […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Otolaryngology/Ear, Nose & Throat (ENT), Pharmaceutical, Regulatory/Compliance, Research & Development, Wall Street Beat Tagged With: Pavmed

Pavmed to drop 510(k), pursue de novo pathway for PortIO infusion system

October 4, 2017 By Sarah Faulkner

Pavmed Inc. (NSDQ:PAVM) plans to drop the 510(k) application for its PortIO intraosseous infusion system and instead pursue a de novo pathway for its device, according to a document the company filed with the SEC yesterday. The move is based on a recommendation from the FDA, the company said. Get the full story at our sister site, Drug […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceutical, Wall Street Beat Tagged With: Pavmed

Pavmed beats Q2 EPS by a penny

August 14, 2017 By Sarah Faulkner

Medical device maker Pavmed Inc. (NSDQ:PAVM) topped expectations on Wall Street with its second quarter results today. The New York-based company posted a net loss of -$989,707, or -8¢ per share, for the 3 months ended June 30, for bottom-line growth of 25% compared with the same period last year. Get the full story at our sister […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Pavmed

Pavmed raises $5m in private placement

July 10, 2017 By Fink Densford

Pavmed (NSDQ:PAVM) said today it closed a $5 million private placement through the sale of senior notes and Series S warrants. Funding in the private placement came from Scopia Holdings, who elected Dr. David Battleman to New York-based Pavmed’s board of directors as part of the financing. “I look forward to joining the PAVmed team as a […]

Filed Under: Business/Financial News Tagged With: Pavmed

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS